BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3542383)

  • 1. Adjuvant therapy of breast cancer: compliance and data validity in a multicenter trial.
    Ryden S; Möller T; Hafström L; Ranstam J; Westrup C; Wiklander O
    Control Clin Trials; 1986 Dec; 7(4):290-305. PubMed ID: 3542383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial.
    Ganz PA; Day R; Costantino J
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):613-22. PubMed ID: 9549810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surgeon and adjuvant therapy for breast cancer.
    Kitchen PR
    Aust N Z J Surg; 1989 Oct; 59(10):761-5. PubMed ID: 2684120
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
    Coates A; Gebski V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):533-40. PubMed ID: 9549802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Herceptin in primary breast cancer: views from North America and Europe.
    Leyland-Jones B; Smith I
    Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.
    Gelber RD; Goldhirsch A
    J Clin Oncol; 1986 Nov; 4(11):1696-703. PubMed ID: 3772421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General evaluation of adjuvant chemotherapy trials in breast cancer (excluding the Milan trial)].
    Gest J
    Bull Cancer; 1984; 71(4):336-44. PubMed ID: 6388672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 12. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial.
    Tennvall-Nittby L; Tengrup I; Landberg T
    Acta Oncol; 1993; 32(6):641-6. PubMed ID: 8260183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].
    van Nes JG; Nortier WR; van de Velde CJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1978-80. PubMed ID: 16171107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast tumours: adjuvant radiotherapy trials.
    Plagne R
    Drugs Exp Clin Res; 1986; 12(1-3):159-65. PubMed ID: 3525071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of primary breast cancer. Closing summary and outlook.
    Glick JH
    Recent Results Cancer Res; 1989; 115():283-92. PubMed ID: 2696039
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
    Gianni L; Dafni U; Gelber RD; Azambuja E; Muehlbauer S; Goldhirsch A; Untch M; Smith I; Baselga J; Jackisch C; Cameron D; Mano M; Pedrini JL; Veronesi A; Mendiola C; Pluzanska A; Semiglazov V; Vrdoljak E; Eckart MJ; Shen Z; Skiadopoulos G; Procter M; Pritchard KI; Piccart-Gebhart MJ; Bell R;
    Lancet Oncol; 2011 Mar; 12(3):236-44. PubMed ID: 21354370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy of breast cancer.
    Carroll RR
    J Med Assoc Ga; 1985 Nov; 74(11):758-9. PubMed ID: 3908609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.